Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?
Clinical Rheumatology pp 1-5; doi:10.1007/s10067-021-05724-5
The publisher has not yet granted permission to display this abstract.
Keywords: Antiphospholipid antibodies / COVID-19 / Inflammation / Thrombosis
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Clinical Rheumatology" .